Adjuvant chemotherapy of cisplatin, 5-fluorouracil and leucovorin for complete resectable esophageal cancer: a case-matched cohort study in east China.

Zhang, J; Zhang, Y W; Chen, Z W; Zhou, X Y; Lu, S; Luo, Q Q; Hu, H; Miao, L S; Ma, L F; Xiang, J Q

Zhang, J; Zhang, Y W; Chen, Z W; Zhou, X Y; Lu, S; Luo, Q Q; Hu, H; Miao, L S; Ma, L F; Xiang, J Q.

Affiliation

Zhang J; Department of Thoracic Surgery, Shanghai Cancer Hospital, Fudan University, Shanghai, China. zhang245@shca.org.cn

Dis Esophagus ; 21(3): 207-13, 2008.

Article in En | MEDLINE | ID: mdl-18430100

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Esophageal Neoplasms/drug therapy; Esophageal Neoplasms/surgery; Adult; Aged; Chemotherapy, Adjuvant; China; Cisplatin/administration & dosage; Cohort Studies; Disease-Free Survival; Female; Fluorouracil/administration & dosage; Humans; Leucovorin/administration & dosage; Male; Middle Aged

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Esophageal Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Country/Region as subject: Asia Language: En Journal: Dis Esophagus Year: 2008 Type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google